2014
DOI: 10.1177/0022042614542512
|View full text |Cite
|
Sign up to set email alerts
|

Different Patterns of Drug Use and Barriers to Continuous HIV Care Post-Incarceration

Abstract: Individuals with a drug use history often experience drug use relapse when they are released from incarceration. This article explores the processes by which a sample of adults experienced relapse post-incarceration and consequently experienced HIV treatment interruption. Data are from in-depth interviews with 25 formerly incarcerated HIV-positive adults who have a self-reported history of drug use. Findings reveal that each participant relapsed post-incarceration. Some participants relapsed immediately after … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 25 publications
0
17
0
Order By: Relevance
“…Release from prison has been associated with engaging in high-risk IDU behaviour, with some studies reporting a rapid return to substance use following release from prison (Shewan et al, 2001;Kinner, 2006;Evans et al, 2009;Milloy et al, 2009;Binswanger et al, 2012), unemployment (Visher et al, 2011), homelessness (Evans et al, 2009), disruption or restricted access to drug (Dolan et al, 2005;Stallwitz and Stöver, 2007;Fu et al, 2013) and other medical treatment programs (Milloy et al, 2011), and recidivism (Håkansson and Berglund, 2012;Kirwan et al, 2015). For ex-prisoners, IDU carries a high risk of fatal (Merrall et al, 2010) and non-fatal (Winter et al, 2015) overdose, infectious disease acquisition and transmission (Dolan et al, 2005), and other poor health and social outcomes (Kinner, 2006;Mallik-Kane and Visher, 2008;Swan, 2015). There is increasingly compelling evidence that improving health outcomes for ex-prisoners has considerable individual and societal benefits (Kinner and Wang, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Release from prison has been associated with engaging in high-risk IDU behaviour, with some studies reporting a rapid return to substance use following release from prison (Shewan et al, 2001;Kinner, 2006;Evans et al, 2009;Milloy et al, 2009;Binswanger et al, 2012), unemployment (Visher et al, 2011), homelessness (Evans et al, 2009), disruption or restricted access to drug (Dolan et al, 2005;Stallwitz and Stöver, 2007;Fu et al, 2013) and other medical treatment programs (Milloy et al, 2011), and recidivism (Håkansson and Berglund, 2012;Kirwan et al, 2015). For ex-prisoners, IDU carries a high risk of fatal (Merrall et al, 2010) and non-fatal (Winter et al, 2015) overdose, infectious disease acquisition and transmission (Dolan et al, 2005), and other poor health and social outcomes (Kinner, 2006;Mallik-Kane and Visher, 2008;Swan, 2015). There is increasingly compelling evidence that improving health outcomes for ex-prisoners has considerable individual and societal benefits (Kinner and Wang, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…There were several individual‐level factors that affected linkage to HIV care following release. Unstable housing or homelessness were the most common barriers to HIV care post‐release . Conversely, Booker et al found that inmates with stable housing 30 days post‐release were over four times more likely to be linked to HIV care .…”
Section: Resultsmentioning
confidence: 99%
“…This conclusion has important implications for misattribution. For example, Swan (2015) found that illicit drug users reported sometimes attributing symptoms to that drug use, rather than disease. A patient may incorrectly attribute their symptom to ARVs, rather than something else that may be causing the symptom, which could have implications for their adherence.…”
Section: Discussionmentioning
confidence: 99%
“…Several barriers to ARV medication adherence have been identified in the literature, such as drug use and mental health disorders (Aragonés, Sánchez, Campos, & Pérez, 2011; Keuroghlian et al, 2011; Malta, Strathdee, Magnanini, & Bastos, 2008; Mellins, Kang, Leu, Havens, & Chesney, 2003; Phillips, 2011; Swan, 2015), unstable housing or homelessness (Lanier & Paoline III, 2005; Meyer, Chen, & Springer, 2011; Nunn et al, 2010; Phillips, 2011; Rebholz, Drainoni, & Cabral, 2009; Rich et al, 2001), and experiencing side effects (Gay et al, 2011; Kremer et al, 2009; Lenzi, Wiens, & Pontarolo, 2013). Attributing symptoms to HIV medications (i.e., as side effects) is associated with switching ARVs, and poor retention/adherence to care (Batchelder, Gonzalez, & Berg, 2014; Kremer et al, 2009; Lenzi, et al, 2013).…”
Section: Introductionmentioning
confidence: 99%